Report updated May 19, 2026
Davis's Drug Guide - Nurses
For nursing students, practicing nurses, physicians, and pharmacists requiring reliable, updated medication reference data.
Davis's Drug Guide - Nurses is an established medical app that is available. With a 4.8/5 rating from 11.1K reviews, it shows polarized user reception. Users particularly appreciate succinct medication monographs provide reliable clinical reference for nursing students and practitioners, though subscription and login errors prevent access to paid content across devices remains a common concern.
What is Davis's Drug Guide - Nurses?
Davis's Drug Guide is a medical reference app for nurses and physicians providing drug monographs, IV calculators, and pill identification tools on iOS and Android.
Users hire the app to ensure medication safety and clinical accuracy during high-stakes nursing shifts, where reliable, updated dosing data is a professional requirement.
Current Momentum
v1.57 · 5d ago
Maintenance- Added pediatric and adult immunization appendix.
- Upgraded payment technology for purchase reliability.
Active Nemesis
Drugs.com Medication Guide
By Drugs.com
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
Recent User MoodAI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.
What makes this app unique?
What Does It Look Like?
How Is The App's Momentum Right Now?
Loading...
What Are The Key Features?
1,700+ entries covering 5,000+ trade and generic medications with safety alerts and REMS data
Integrated tools for calculating drips and dosing directly within the app
Cross-platform access to the database via web browser after app purchase
How much does it cost?
- 14-day free trial
- $39.99 for a one-year subscription
Subscription model anchored at $39.99/year, utilizing a free trial period to convert students and professionals into annual recurring revenue.
Who Built It?
Unbound Medicine
Equipping healthcare professionals with evidence-based clinical decision support and integrated reference tools at the point of care.
Portfolio
13
Apps
Who is Unbound Medicine?
Unbound Medicine has established a defensible position by pivoting from standalone medical utilities to integrated clinical suites that consolidate multiple peer-reviewed references into a single workflow. Their primary moat is a network of high-prestige institutional partnerships, including Johns Hopkins Medicine and the American Academy of Pediatrics, which provides a level of authoritative credibility difficult for pure-tech competitors to replicate. The recent acquisition by MPS Limited marks a strategic inflection point, signaling an move toward international expansion and the integration of AI-driven tools into their existing evidence-based platform.
Who is Unbound Medicine for?
- Professional nurses
- Physicians
- Medical students
- Researchers requiring mobile access to peer-reviewed clinical data
Portfolio momentum
With 92 releases across 53 active apps in the last 6 months, the publisher maintains an exceptionally high update cadence for its clinical databases.
What other apps does Unbound Medicine make?
DSM-5-TR® Diagnosis Handbook
5-Minute Emergency Medicine
Johns Hopkins Antibiotic Guide
Nursing Central
Oxford Handbook Clinical Med
Oxford Emergency Medicine
What do users think recently?
High confidence · Latest 70 of 102 total reviews analyzed · Based on 102 reviews. Signal may be noisy.
How did the latest release land?
What is the recent mood?
Recent user voice shows a mixed sentiment. Users appreciate succinct medication monographs provide reliable clinical reference for nursing students and practitioners and integrated dosage and infusion calculators assist with critical medication safety checks, but report subscription and login errors prevent access to paid content across devices and transition to a mandatory subscription model alienates users who previously accessed content via textbooks.
What Users Love
What Frustrates Users
What Users Want
What is the competitive landscape for Davis's Drug Guide - Nurses?
How's The Medical Market?
How does it evolve in the Medical market?
Davis's Drug Guide holds the #10 Grossing position in the US Medical category, but the gap between its high utility and the #30-34 rankings in international markets suggests the $39.99/year price point is a barrier to global adoption.
| Country | Category | Chart | Rank | Change |
|---|---|---|---|---|
| 🇩🇿 Algeria | Medical | AndroidGrossing | #34 | ▼1 |
| 🇵🇾 Paraguay | Medical | iOSGrossing | #64 | ▲3 |
The rivals identified
The Nemesis
Head to Head
The target app should double down on its specialized nursing-specific clinical utility to differentiate from the broader, general-purpose reach of Drugs.com.
What sets Davis's Drug Guide - Nurses apart
Delivers specialized, clinically-focused content tailored specifically for nursing workflows and medication administration safety
Includes exclusive, integrated access to DrugGuide.com which provides a more curated experience for professional medical practitioners
What's Drugs.com Medication Guide's Edge
Leverages a massive, cross-platform user base that creates a significant data-driven network effect for drug information
Provides a more versatile, general-purpose medication toolset that appeals to a wider audience beyond just nursing professionals
Contenders
Medscape
★3.7 (63.9K)WebMD
⚡High-velocity release cadence with 14 updates in six months signals a massive, aggressive push for clinical dominance.
Integrates a massive, multi-specialty clinical news feed that keeps users engaged beyond simple drug lookups
Provides a comprehensive suite of CME-accredited courses directly within the app to drive professional retention
UpToDate
★4.3 (11.3K)UpToDate, Inc.
🚀The gold standard for clinical decision support, serving as a high-barrier-to-entry alternative for medical professionals.
Focuses on evidence-based clinical decision support rather than just medication reference and dosing calculators
Requires institutional or professional subscriptions, creating a high-value, gated experience for serious medical practitioners
Peers
Skyscape Medical Library
★4.8 (3K)Skyscape Medpresso Inc
🚀Offers a modular library approach that allows users to build a custom collection of medical references.
Utilizes a modular, 'a la carte' content delivery model that lets users purchase specific medical texts
Provides a highly customizable interface for managing multiple medical references within a single unified library
Calculate by QxMD
★4.5 (13.2K)WebMD
📈Focuses specifically on clinical calculators and decision tools rather than comprehensive drug monographs.
Specializes in high-utility clinical calculators that solve specific, time-sensitive diagnostic problems for clinicians
Optimized for rapid, point-of-care decision support rather than long-form medication reference and safety data
Merck Manual Professional
★4.8 (999)Merck & Co Inc
🚀A highly respected, authoritative medical reference that serves as a trusted, static knowledge base.
Provides authoritative, peer-reviewed medical content that is widely recognized as a standard clinical reference
Maintains a clean, text-heavy interface that prioritizes clinical accuracy and depth over interactive features
New Kids on the Block
Simplifies the complex drug identification process into a streamlined, visual-first user experience for rapid results
Targets the specific 'what is this pill?' user intent that often leads to broader medication guide discovery
The outtake for Davis's Drug Guide - Nurses
Strengths to defend, gaps to attack
Core Strengths
- Integrated IV calculators function as a daily-use clinical retention loop
- Exclusive DrugGuide.com web access creates a multi-surface professional workflow
Critical Frictions
- 0.06★ rating gap between iOS and Android indicates authentication instability
- $39.99/year subscription model lacks a one-time purchase option for legacy users
Growth Levers
- Dark mode implementation would address the #1 UI-specific request for night-shift staff
- License portability across platforms would reduce the high-frequency login complaint
Market Threats
- Drugs.com's free pill identification tool captures top-of-funnel users
- Mandatory subscription shifts alienate the core nursing student segment
What are the next best moves?
Ship account-based license portability because login errors are the top-cited churn driver → increase retention
User reviews consistently cite inability to restore purchases or access content across devices.
Trade-off: Deprioritize the planned UI refresh for the monograph search interface.
Audit authentication logic because subscription-access failures are suppressing sentiment → improve rating baseline
Sentiment analysis shows high-frequency complaints regarding subscription recognition post-update.
Trade-off: Same-quarter capacity available — no major lever displaced.
A counter-intuitive read
The #10 Grossing rank is a vulnerability: the app's reliance on a $39.99/year subscription model creates a price ceiling that allows free, ad-supported competitors to capture the high-volume student market.
Feature Gaps vs Competitors
- Real-time clinical news feed (available in Medscape but absent here)
- CME-accredited course integration (available in Medscape but absent here)
Key Takeaways
Davis's Drug Guide maintains clinical authority through its integrated calculators, but the recurring authentication failures threaten its subscription revenue, so the PM must prioritize account-based license portability to stop the churn of professional users.
Where Is It Heading?
Declining
The clinical reference market is consolidating around high-velocity, multi-surface tools, leaving Davis's Drug Guide exposed due to its rigid subscription-only model and authentication friction. If the team does not solve the cross-platform login issue, the current #10 Grossing rank will likely erode as users migrate to more stable, free-to-access alternatives.
Persistent authentication failures post-update erode professional trust, which directly suppresses the app's long-term subscription renewal rate.
The shift to a mandatory subscription model alienates legacy textbook users, accelerating churn among the core nursing student segment.